FDA Inspection
Dextrum Laboratories Inc.Dextrum Laboratories Inc. – FDA Inspection, Feb 12, 2016
Record Details
This FDA Inspection record concerns Dextrum Laboratories Inc., with an inspection on February 12, 2016, issued by the Center for Drug Evaluation and Research, covering drugs.
- Company
- Dextrum Laboratories Inc.
- Inspection Date
- February 12, 2016
- Product Type
- Drugs
View Company Profile
ID · 87b19929-69bf-4019-9f25-5647d5242055
Inspection Facts
Voluntary Action Indicated (VAI)
Objectionable conditions were found, but FDA is not prepared to take or recommend regulatory action.
- Inspection number
- 965268
- FDA center
- Human Drugs
- Project area
- Drug Quality Assurance
FDA Citations
6- 21 CFR 211.110(a)Control procedures to monitor and validate performance
- 21 CFR 211.84(d)(6)Microbiological Contamination Exam
- 21 CFR 211.84(d)(2)Reports of Analysis (Components)
- 21 CFR 211.165(a)Testing and release for distribution
- 21 CFR 211.100(a)Absence of Written Procedures
- 21 CFR 211.122(a)Written procedures describing in detail
Full citation text and observation details available on the Dashboard.
Other FDA inspections of Dextrum Laboratories Inc.
5| Date | Classification | Office | Project area |
|---|---|---|---|
| August 29, 2024 | OAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| July 18, 2023 | OAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| December 16, 2022 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| November 17, 2017 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| July 10, 2012 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
Other documents for Dextrum Laboratories Inc.
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.